These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1199 related articles for article (PubMed ID: 23527911)
1. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis. Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911 [TBL] [Abstract][Full Text] [Related]
2. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model. Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis. Cremers B; Milewski K; Clever YP; Aboodi MS; Biedermann M; Thim T; Kelsch B; Kaluza GL; Scheller B; Granada JF Catheter Cardiovasc Interv; 2012 Oct; 80(4):603-10. PubMed ID: 22511557 [TBL] [Abstract][Full Text] [Related]
4. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
5. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial. Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F Trials; 2012 May; 13():55. PubMed ID: 22559260 [TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis. Pleva L; Kukla P; Zapletalova J; Hlinomaz O BMC Cardiovasc Disord; 2017 Jun; 17(1):168. PubMed ID: 28651572 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter). Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609 [TBL] [Abstract][Full Text] [Related]
9. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study. Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries. Wöhrle J; Werner GS Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572 [TBL] [Abstract][Full Text] [Related]
11. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent. Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589 [TBL] [Abstract][Full Text] [Related]
13. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
14. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731 [TBL] [Abstract][Full Text] [Related]
15. Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis. Kong J; Deng Y; Dong Q; Liu W; Lu Y Arch Med Res; 2015 Feb; 46(2):101-6. PubMed ID: 25660338 [TBL] [Abstract][Full Text] [Related]
16. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737 [TBL] [Abstract][Full Text] [Related]
17. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial. Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939 [TBL] [Abstract][Full Text] [Related]
18. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis. Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial. Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA; JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022 [TBL] [Abstract][Full Text] [Related]
20. A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial. Baan J; Claessen BE; Dijk KB; Vendrik J; van der Schaaf RJ; Meuwissen M; van Royen N; Gosselink ATM; van Wely MH; Dirkali A; Arkenbout EK; de Winter RJ; Koch KT; Sjauw KD; Beijk MA; Vis MM; Wykrzykowska JJ; Piek JJ; Tijssen JGP; Henriques JPS JACC Cardiovasc Interv; 2018 Feb; 11(3):275-283. PubMed ID: 29413242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]